Semnur Pharmaceuticals Inc (SMNRW)

$0.20 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 4,100
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 71%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Semnur Pharmaceuticals, Inc. develops and markets non-opioid drugs to treat back pain. The company was incorporated in 2013 and is based in Los Altos, California. Semnur Pharmaceuticals, Inc. operates as a subsidiary of Scilex Holding Company.

Phone: 888 315 8706
Address:
4970 El Camino Real, Suite 205, Los Altos, United States
Latest News on SMNRW
No data available.